Men are more likely than women to benefit from the use of a clot-busting drug after stroke, according to a study published in the March 13, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Almost one-third of returning veterans who received health care at Veterans Affairs facilities between 2001 and 2005 were given a mental health or psychosocial diagnosis, according to a report in the March 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
In response to the FDA’s recent public health advisory citing potential dangers of overusing Erythropoiesis-Stimulating Agents (ESAs), the Renal Physicians Association (RPA) urges caution among its doctors and patients when considering any changes to anemia management regimens.
3M Health Care announced the launch of a new Medical Diagnostics business unit that will focus on developing and commercializing rapid diagnostic product solutions for the detection of key infectious pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and other treatment-resistant microbes.
Understanding the link between Polycystic Ovary Syndrome (PCOS) and insulin resistance is the aim of a new project announced today, funded by the charity WellBeing of Women.
Advances in radiation therapy for cancer have made it possible to fine-tune radiation beams so they match the shape and position of a patient’s tumor nearly anywhere in the body.
Most postmenopausal women with small breast tumors don?t need chemotherapy to reduce their recurrence risk after lumpectomy.
Scientists have highlighted for the first time the plight of the growing number of older children and adolescents living with undiagnosed HIV and AIDS in Africa.
In observance of National Women and Girls HIV/AIDS Awareness Day on March 10, 2007, Vivian Berryhill, president of the National Coalition of Pastors’ Spouses, issued the following statement urging women of all ages to be routinely tested for HIV:
Takeda and FDA notified healthcare professionals of recent safety data concerning pioglitazone-containing products. The results of an analysis of the manufacturer’s clinical trial database of pioglitazone showed more reports of fractures in female patients taking pioglitazone than those taking a comparator (either placebo or active).